Choi P, Merriman E, Bennett A, Enjeti A, Tan C, Goncalves I
Med J Aust. 2021; 216(1):43-52.
PMID: 34628650
PMC: 9293212.
DOI: 10.5694/mja2.51284.
Liu W, Wu D, Hu T, Ye B
Int J Clin Exp Med. 2015; 8(8):14080-4.
PMID: 26550372
PMC: 4613057.
Provan D, Newland A
Adv Ther. 2015; 32(10):875-87.
PMID: 26499177
PMC: 4635183.
DOI: 10.1007/s12325-015-0251-z.
Kashiwagi H, Tomiyama Y
Int J Hematol. 2013; 98(1):24-33.
PMID: 23702914
DOI: 10.1007/s12185-013-1370-4.
Bluml S, McKeever K, Ettinger R, Smolen J, Herbst R
Arthritis Res Ther. 2013; 15 Suppl 1:S4.
PMID: 23566679
PMC: 3624127.
DOI: 10.1186/ar3906.
Spontaneous improvement of chronic immune thrombocytopenia in children: experience of 56 patients at a single institute.
Kato M, Koh K, Kikuchi A, Hanada R
Int J Hematol. 2012; 96(6):729-32.
PMID: 23104260
DOI: 10.1007/s12185-012-1211-x.
Thrombotic thrombocytopenic purpura: a review of the literature in the light of our experience with plasma exchange.
Rizzo C, Rizzo S, Scire E, Di Bona D, Ingrassia C, Franco G
Blood Transfus. 2012; 10(4):521-32.
PMID: 22790258
PMC: 3496241.
DOI: 10.2450/2012.0122-11.
Immune thrombocytopenia: no longer 'idiopathic'.
McCrae K
Cleve Clin J Med. 2011; 78(6):358-73.
PMID: 21632906
PMC: 3410635.
DOI: 10.3949/ccjm.78gr.10005.
Rituximab in immune thrombocytopenia: transient responses, low rate of sustained remissions and poor response to further therapy in refractory patients.
Aleem A, Alaskar A, Algahtani F, Rather M, Almahayni M, Al-Momen A
Int J Hematol. 2010; 92(2):283-8.
PMID: 20640541
DOI: 10.1007/s12185-010-0635-4.
Successful treatment with rituximab of refractory idiopathic thrombocytopenic purpura in a patient with Kabuki syndrome.
Torii Y, Yagasaki H, Tanaka H, Mizuno S, Nishio N, Muramatsu H
Int J Hematol. 2009; 90(2):174-176.
PMID: 19662467
DOI: 10.1007/s12185-009-0387-1.
B-cell-directed therapies for autoimmune disease.
Dorner T, Radbruch A, Burmester G
Nat Rev Rheumatol. 2009; 5(8):433-41.
PMID: 19581902
DOI: 10.1038/nrrheum.2009.141.
[Translational aspects on the role of B-cells in autoimmune diseases. "From bench to bedside" and "from bed to benchside"].
Mei H, Dorner T
Z Rheumatol. 2009; 68(5):364-9.
PMID: 19513730
DOI: 10.1007/s00393-009-0436-4.
Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura.
Goto S, Goto H, Tanoshima R, Kato H, Takahashi H, Sekiguchi O
Int J Hematol. 2009; 89(3):305-309.
PMID: 19308659
DOI: 10.1007/s12185-009-0269-6.
Rituximab therapy in a patient with autoimmune hemolytic anemia and immune thrombocytopenia associated with chronic lymphocytic leukemia.
Aleem A
Ann Saudi Med. 2008; 28(5):382-5.
PMID: 18779631
PMC: 6074481.
DOI: 10.5144/0256-4947.2008.382.
Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy.
Machado P, Raya J, Martin T, Morabito L, Brito M, Rodriguez-Martin J
Int J Hematol. 2008; 87(5):545-549.
PMID: 18414981
DOI: 10.1007/s12185-008-0077-4.
The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura.
Pasa S, Altintas A, Cil T, Danis R, Ayyildiz O
J Thromb Thrombolysis. 2008; 27(3):329-33.
PMID: 18311541
DOI: 10.1007/s11239-008-0208-z.
Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment.
Parodi E, Nobili B, Perrotta S, Matarese S, Russo G, Licciardello M
Int J Hematol. 2006; 84(1):48-53.
PMID: 16867902
DOI: 10.1532/IJH97.E0518.
[Adult autoimmune thrombocytopenia: diagnosis and treatment].
Lechner K, Weltermann A, Pabinger I
Wien Klin Wochenschr. 2006; 118(9-10):255-64.
PMID: 16810482
DOI: 10.1007/s00508-006-0602-5.
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura.
Bennett C, Rogers Z, Kinnamon D, Bussel J, Mahoney D, Abshire T
Blood. 2005; 107(7):2639-42.
PMID: 16352811
PMC: 1895391.
DOI: 10.1182/blood-2005-08-3518.
Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura.
Kojouri K, George J
Int J Hematol. 2005; 81(2):119-25.
PMID: 15765779
DOI: 10.1532/ijh97.04173.